The University of Texas MD Anderson Cancer Center
Departments of Clinical Research and Breast Medical Oncology
My research interests have been defining and improving the short- and long-term benefits of systemic adjuvant therapies for breast cancer. My colleagues and I demonstrated that fluorouracil, doxorubicin, and cyclophosphamide (FAC) chemotherapy before surgery is effective in reducing the risk of recurrence and substantially improves the odds of remaining free of disease for women with operable breast cancer.
Education & Training
M.D. - Nishtar Medical College - 1967